Prospective comparison of hybrid 68Ga-PSMA PET/CT and PET/MR in patients with biochemically recurrent prostate cancer

被引:0
|
作者
Jentjens, S. [1 ]
Mai, C. [1 ]
De Coster, L. [2 ]
Bidakhvidi, N. Ahmadi [1 ]
Mertens, N. [1 ]
Everaerts, W. [1 ]
Joniau, S. [1 ]
Oyen, R. [1 ]
Van Laere, K. [1 ]
Goffin, K. [1 ]
机构
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Europe Hosp, Brussels, Belgium
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0135
引用
收藏
页码:S445 / S445
页数:1
相关论文
共 50 条
  • [31] 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
    Ceci, Francesco
    Uprimny, Christian
    Nilica, Bernhard
    Geraldo, Llanos
    Kendler, Dorota
    Kroiss, Alexander
    Bektic, Jasmin
    Horninger, Wolfgang
    Lukas, Peter
    Decristoforo, Clemens
    Castellucci, Paolo
    Fanti, Stefano
    Virgolini, Irene J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (08) : 1284 - 1294
  • [32] Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients
    M Celli
    U De Giorgi
    P Caroli
    V Di Iorio
    L Fantini
    V Rossetti
    F Foca
    S Nicolini
    M Giganti
    G Paganelli
    F Matteucci
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 87 - 94
  • [33] Reply: "The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer"
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    [J]. UROLOGY, 2019, 131 : 262 - 263
  • [34] LCerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT
    Chan, Mico
    Hsiao, Edward
    Turner, Jennifer
    [J]. CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 193 - 194
  • [35] The use of 68Ga-PSMA PET/CT following radical prostatectomy for suspected biochemically recurrent disease
    Raveenthiran, S.
    Yaxley, J.
    Yaxley, A.
    Coughlin, G.
    Yaxley, W.
    Gianduzzo, T.
    Kua, B.
    Pokorny, M.
    McEwan, L.
    Wong, D.
    [J]. BJU INTERNATIONAL, 2019, 123 : 24 - 25
  • [36] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
    Algin, Efnan
    Okudan, Berna
    Acikgoz, Yusuf
    Sayan, Haluk
    Bal, Oznur
    Seven, Bedri
    [J]. CURRENT MEDICAL IMAGING, 2024, 20
  • [37] Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT
    Yin, Charlotte
    Ho, Bao
    Chan, Lyn
    Emmett, Louise
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E382 - E384
  • [38] 68Ga-PSMA PET/CT; current impact on management in prostate cancer
    Intema, F.
    Kooistra, A.
    Lont, A. P.
    Hendriks, L. P. J.
    Esser, J. P.
    Lange, R.
    de Klerk, J. M. H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S707 - S707
  • [39] Primary staging of prostate cancer using 68Ga-PSMA PET/CT
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Gasparro, D.
    Maestroni, U.
    Ruffini, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S599 - S600
  • [40] 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
    Christos Sachpekidis
    P. Bäumer
    K. Kopka
    B. A. Hadaschik
    M. Hohenfellner
    A. Kopp-Schneider
    U. Haberkorn
    A. Dimitrakopoulou-Strauss
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 904 - 912